ChristianGrommesMD

Neuro-Oncology

Attending, Neurology & Neuro-Oncology, Memorial Sloan Kettering Cancer Center

Overview of Dr. Grommes

Dr. Christian Grommes is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from RWTH Aachen University FOM and has been in practice 18 years. Dr. Grommes accepts several types of health insurance, listed below. He is one of 493 doctors at Memorial Sloan Kettering Cancer Center and one of 90 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. He also speaks multiple languages, including German. He has more than 80 publications and over 500 citings.

Office
160 East 53rd Street
New York, NY 10022
Book by Phone+1(321) 338-1158

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 2009 - 2011
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurology, 2006 - 2009
Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Internal Medicine, 2005 - 2006
University Hospitals Cleveland Medical CenterPost-Doctoral Fellowship, 2002 - 2005
University of BonnResidency, Neurology, 2000 - 2002
RWTH Aachen University FOMClass of 2000, MD

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 2009 - 2026
VA State Medical License 2021 - 2026
NJ State Medical License 2023 - 2025
OH State Medical License 2005 - 2025
PA State Medical License 2022 - 2024
American Board of Psychiatry and Neurology Neurology
United Council for Neurologic SubspecialtiesNeuro-Oncology

Clinical Trials

Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL) Start of enrollment: 2018 Aug 23
Active, not recruiting
Phase 1, Phase 2
LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma Start of enrollment: 2018 Nov 14
Recruiting
Early Phase 1
Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL) Start of enrollment: 2019 Jan 22
Active, not recruiting
Phase 1
Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma Start of enrollment: 2018 Nov 12
Active, not recruiting
Phase 2
Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) Start of enrollment: 2021 Dec 29
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy Start of enrollment: 2020 May 22
Active, not recruiting
Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

93 citations
Genomic correlates of disease progression and treatment response in prospectively characterized gliomas
Philip Jonsson, Andrew L. Lin, Robert J. Young, Natalie DiStefano, David M. Hyman
Clinical Cancer Research. 2019-09-15
864 citations
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle, Janeta Popovici-Muller, Nicolaos Palaskas, Sevin Turcan, Christian Grommes
Science. 2013-05-03
344 citations
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
Alexandra Miller, Ronak Shah, Elena Pentsova, Maryam Pourmaleki, Samuel Briggs
Nature. 2019-01-01

Journal Articles

Phase I Study of Pomalidomide and Dexamethasone for relapsed/refractory Primary CNS or Vitreo-Retinal Lymphoma
Lisa M DeAngelis, Han W Tun, David Schiff, Kurt A Jaeckle, Christian Grommes, Patrick B Johnston, Craig B Reeder, Thomas E Witzig, Blood

Abstracts/Posters

Increased Number of High Dose Methotrexate Cycles and the Addition of Rituximab Is Associated with Better Outcomes in a Large Primary CNSL Cohort
Christian Grommes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Treatment of Primary Central Nervous System Lymphoma: From Chemotherapy to Small Molecules
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Professional Memberships

American Academy of Neurology - AAN
Member
American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member
Society of Neuro-Oncology
Member

Other Languages

German

External Links

MSKCChttps://www.mskcc.org/cancer-care/doctors/christian-grommes

Insurance Accepted

BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment